173 related articles for article (PubMed ID: 7905505)
1. Effects of human T lymphocyte activation on inosine monophosphate dehydrogenase expression.
Dayton JS; Lindsten T; Thompson CB; Mitchell BS
J Immunol; 1994 Feb; 152(3):984-91. PubMed ID: 7905505
[TBL] [Abstract][Full Text] [Related]
2. Selective up-regulation of type II inosine 5'-monophosphate dehydrogenase messenger RNA expression in human leukemias.
Nagai M; Natsumeda Y; Konno Y; Hoffman R; Irino S; Weber G
Cancer Res; 1991 Aug; 51(15):3886-90. PubMed ID: 1677309
[TBL] [Abstract][Full Text] [Related]
3. Type I inosine monophosphate dehydrogenase: evidence for a single functional gene in mammalian species.
Dayton JS; Mitchell BS
Biochem Biophys Res Commun; 1993 Sep; 195(2):897-901. PubMed ID: 7690562
[TBL] [Abstract][Full Text] [Related]
4. Proliferation-linked regulation of type II IMP dehydrogenase gene in human normal lymphocytes and HL-60 leukemic cells.
Nagai M; Natsumeda Y; Weber G
Cancer Res; 1992 Jan; 52(2):258-61. PubMed ID: 1345808
[TBL] [Abstract][Full Text] [Related]
5. Effects of mycophenolic acid on inosine monophosphate dehydrogenase I and II mRNA expression in white blood cells and various tissues in sheep.
Dzidic A; Prgomet C; Mohr A; Meyer K; Bauer J; Meyer HH; Pfaffl MW
J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):163-9. PubMed ID: 16629948
[TBL] [Abstract][Full Text] [Related]
6. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.
Zimmermann AG; Gu JJ; Laliberté J; Mitchell BS
Prog Nucleic Acid Res Mol Biol; 1998; 61():181-209. PubMed ID: 9752721
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene.
Gu JJ; Stegmann S; Gathy K; Murray R; Laliberte J; Ayscue L; Mitchell BS
J Clin Invest; 2000 Aug; 106(4):599-606. PubMed ID: 10953035
[TBL] [Abstract][Full Text] [Related]
9. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
[TBL] [Abstract][Full Text] [Related]
10. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
Vethe NT; Bremer S; Bergan S
Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
[TBL] [Abstract][Full Text] [Related]
11. Effects of the IMP-dehydrogenase inhibitor, Tiazofurin, in bcr-abl positive acute myelogenous leukemia. Part II. In vitro studies.
Wright DG; Boosalis M; Malek K; Waraska K
Leuk Res; 2004 Nov; 28(11):1137-43. PubMed ID: 15380336
[TBL] [Abstract][Full Text] [Related]
12. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal localization and structure of the human type II IMP dehydrogenase gene (IMPDH2).
Glesne D; Collart F; Varkony T; Drabkin H; Huberman E
Genomics; 1993 Apr; 16(1):274-7. PubMed ID: 8098009
[TBL] [Abstract][Full Text] [Related]
14. Cloning, sequencing, and structural analysis of the DNA encoding inosine monophosphate dehydrogenase (EC 1.1.1.205) from Tritrichomonas foetus.
Beck JT; Zhao S; Wang CC
Exp Parasitol; 1994 Feb; 78(1):101-12. PubMed ID: 7905423
[TBL] [Abstract][Full Text] [Related]
15. Assignment of the human type I IMP dehydrogenase gene (IMPDH1) to chromosome 7q31.3-q32).
Gu JJ; Kaiser-Rogers K; Rao K; Mitchell BS
Genomics; 1994 Nov; 24(1):179-81. PubMed ID: 7896275
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function.
Petrova DT; Brandhorst G; Brehmer F; Gross O; Oellerich M; Armstrong VW
Ther Drug Monit; 2010 Aug; 32(4):405-12. PubMed ID: 20592645
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of inosine 5-monophosphate dehydrogenase in Streptococcus suis type 2.
Zhang XH; He KW; Duan ZT; Zhou JM; Yu ZY; Ni YX; Lu CP
Microb Pathog; 2009 Nov; 47(5):267-73. PubMed ID: 19744553
[TBL] [Abstract][Full Text] [Related]
18. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
[TBL] [Abstract][Full Text] [Related]
19. 3-Hydrogenkwadaphnin targets inosine 5'-monophosphate dehydrogenase and triggers post-G1 arrest apoptosis in human leukemia cell lines.
Moosavi MA; Yazdanparast R; Sanati MH; Nejad AS
Int J Biochem Cell Biol; 2005 Nov; 37(11):2366-79. PubMed ID: 16084123
[TBL] [Abstract][Full Text] [Related]
20. Regulation of inosine-5'-monophosphate dehydrogenase type II gene expression in human T cells. Role for a novel 5' palindromic octamer sequence.
Zimmermann AG; Wright KL; Ting JP; Mitchell BS
J Biol Chem; 1997 Sep; 272(36):22913-23. PubMed ID: 9278455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
